Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 488
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT03728361 | Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer | ||
| NCT04774068 | Romidepsin and Parsaclisib for the Treatment of Relapsed or Refractory T-Cell Lymphomas | ||
| NCT05961982 | Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study | ||
| NCT00276120 | Identification of Novel Genetic Factors That Contribute to Risk for Breast Cancer | ||
| NCT00754910 | Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Non-Small Cell Lung Cancer And Bronchial Disease | ||
| NCT03691350 | Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs | ||
| NCT06950008 | A Patient Navigation Intervention for the Improvement of Risk Management Among Women at High Risk of Breast Cancer | ||
| NCT06763536 | Oral Nicotine Pouches Versus Nicotine Replacement Therapy to Reduce Cigarette Use for Smokers in Rural Appalachia | ||
| NCT01589302 | PCI-32765 (Ibrutinib) in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or B-cell Prolymphocytic Leukemia | ||
| NCT01569672 | Ohio Patient Navigator Research Program | ||
| NCT01961869 | Black Raspberry Confection in Preventing Oral Cancer in Healthy Volunteers | ||
| NCT01469429 | Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. | ||
| NCT03258892 | Sarcoma Treatment Guide in Improving Self-Monitoring in Patients With Sarcoma Receiving Chemotherapy | ||
| NCT02303392 | Selinexor and Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Aggressive Non-Hodgkin Lymphoma | ||
| NCT02122081 | Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies | ||
| NCT00017199 | PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors | ||
| NCT07215988 | Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study | ||
| NCT06062901 | An Educational Intervention on Provider Knowledge for the Support of Cancer Survivors | ||
| NCT06315881 | Informing Oral Nicotine Pouch Regulations to Promote Public Health | ||
| NCT04120454 | Ramucirumab and Pembrolizumab for the Treatment of EGFR Mutant Recurrent or Metastatic Non-small Cell Lung Cancer | ||
| NCT04880837 | Human Papillomavirus Education Programs | ||
| NCT05114005 | Tango for Neuropathy Among Breast Cancer Survivors | ||
| NCT02569320 | HDAC Inhibitor AR-42 and Pomalidomide in Treating Patients With Relapsed Multiple Myeloma | ||
| NCT03537599 | Daratumumab and Donor Lymphocyte Infusion in Treating Participants With Relapsed Acute Myeloid Leukemia After Stem Cell Transplant | ||
| NCT06571058 | B3 Buddy for Securing Urinary Drainage Bag to Patient While Walking | ||
| NCT04910152 | Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD | ||
| NCT06230159 | Evaluating the Impact of Synthetic Cooling Agents in Combustible Cigarettes on Smoking Perceptions and Use | ||
| NCT02518555 | Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma | ||
| NCT03665675 | Donor Virus-Specific CMV or AdV CTL to Treat CMV or AdV Reactivation or Disease After Solid Organ or HCT | ||
| NCT00569309 | Immune Reconstitution After Autologous Hematopoietic Stem Cell Transpl for High-Risk Lymphoma | ||
| NCT05304793 | Testing a Cognitive Behavioral Model for Reducing Dyspnea in Patients With Lung Cancer | ||
| NCT00561418 | Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma | ||
| NCT05048108 | Remote Assessment of Cognition, Insulin Resistance and Omega-3 Fatty Acid Biomarkers in Breast Cancer Survivors | ||
| NCT06448351 | Manipulating E-Cigarette Nicotine to Promote Public Health | ||
| NCT07150806 | RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma | ||
| NCT04466683 | Low-Dose Radiotherapy For Patients With SARS-COV-2 (COVID-19) Pneumonia | ||
| NCT01652196 | Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer | ||
| NCT03513562 | Venetoclax and Ibrutinib in Treating in Participants with Chronic Lymphocytic Leukemia and Ibrutinib Resistance Mutations | ||
| NCT07102212 | Telemedicine-mHealth Symptom Cluster Intervention for Advanced Cancer Patients: Finding Our Center Under Stress (FOCUS) | ||
| NCT00837928 | Bendamustine and Radiation Therapy in Treating Patients With Brain Metastases Caused by Solid Tumors | ||
| NCT00201786 | Phase II Trial of Pentostatin in Steroid Refractory Acute Graft Versus Host Disease | ||
| NCT03460483 | Universal Endometrial Cancer DNA Sequencing for Detection of Lynch Syndrome and Personalized Care | ||
| NCT04205903 | Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer | ||
| NCT00293527 | Interferon Alpha-2b (Intron A) for Metastatic or Unresectable Clear Cell Renal Carcinoma | ||
| NCT02035527 | Sorafenib Tosylate, Cisplatin, and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck | ||
| NCT03583424 | Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma | ||
| NCT06026657 | Gemcitabine and Ex Vivo Expanded Allogenic Universal Donor, TGFβi Natural Killer (NK) Cells With or Without Naxitamab (Danyelza) for the Treatment of Patients With Metastatic, GD2 Expressing, HER2 Negative Breast Cancer | ||
| NCT04635683 | Lenalidomide, Umbralisib, and Ublituximab for the Treatment of Relapsed or Refractory Indolent Non-Hodgkin Lymphoma or Mantle Cell Lymphoma | ||
| NCT02944565 | Daratumumab in Treating Patients With Multiple Myeloma | ||
| NCT06112002 | Evaluation of an Education Program to Increase Knowledge and Participation in Clinical Trials Among Racial/Ethnic and Rural Populations |
